NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Healthcare Plans · USD

CVS Health Corporation (CVS) Stock Analysis

CVS Health Corporation (CVS) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.

CVS

$96.74

−$0.46 (−0.47%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CVS with… →

CVS Key Statistics

As of Sep 4, 2026
Trading
Open
$96.59
Previous Close
$97.20
Day's Range
96.29–97.69
52-Week Range
69.51–110.68
Volume
4.50M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.58
Valuation
Market Cap
$123.73B
P/E Ratio
25.66
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
11.36
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.23
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.30
EPS (ttm)Profit attributable to each share over the last twelve months.
3.77
Financials (FY)
Revenue (FY)
$402.07B+7.85%
Net Income (FY)
$1.77B−61.68%
Profit marginThe share of revenue left as profit after all costs and taxes.
1.18%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.28B
1-Year Return
+35.45%
Dividend and dates
Dividend
$2.66+2.74%
Ex-Dividend Date
July 23, 2026
Earnings Date
October 28, 2026estimated
Avg Volume
7.88M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CVS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+24.75%
2025+84.35%
2024−40.77%
2023−12.53%
2022−7.63%
2021+54.87%
2020−5.14%
2019+17.26%
2018−7.04%
2017−5.75%
2016 (partial year)−18.40%

As of September 4, 2026.

CVS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$402.07B$1.77B0.4%
2024$372.81B$4.61B1.2%
2023$357.78B$8.34B2.3%
2022$322.47B$4.31B1.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$402.07B$55.36B$10.39B$1.77B0.4%
2024$372.81B$51.40B$9.70B$4.61B1.2%
2023$357.78B$54.43B$14.60B$8.34B2.3%
2022$322.47B$54.50B$16.29B$4.31B1.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CVS Dividend History

$2.66+0.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$2.003—
2025$2.664+0.0%
2024$2.664+9.9%
2023$2.424+10.0%
YearDividends per sharePaymentsChange
2026 (partial year)$2.003—
2025$2.664+0.0%
2024$2.664+9.9%
2023$2.424+10.0%
2022$2.204+10.0%
2021$2.004+0.0%
2020$2.004+0.0%
2019$2.004+0.0%
2018$2.004+0.0%
2017$2.004+370.6%
2016$0.431—

Most recent payment: $0.67 per share, ex-dividend July 23, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

CVS Valuation vs Healthcare Plans Median

Median of 11 stocks
MetricCVSHealthcare Plans medianvs median
P/E25.6625.660% above
P/S ratio0.300.4432% below
Profit margin1.18%1.18%0.0 pts above

Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

CVS Health Corporation (CVS) is capitalised at $123.73B on the latest close. It is classified in the Healthcare Plans industry, within the Healthcare sector. The company reports 219,000 employees.

The 52-week range on file runs from $69.51 to $110.68. CVS last closed at $96.74 on September 4, 2026. That is −$0.46 (−0.47%) against the previous close. The latest close sits 39.17% above that 52-week low.

Financial Health

In fiscal 2025, CVS Health Corporation reported revenue of $402.07B. Against the prior fiscal year total of $372.81B, that is a change of +7.85%. Net income for the same year was $1.77B. That is −61.68% against the prior fiscal year. Profit margin runs at 1.18%. Earnings per share on a trailing basis come to 3.77.

Across the 4 fiscal years on file, revenue moves from $322.47B in 2022 to $402.07B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

CVS trades at a trailing price-to-earnings ratio of 25.66. That is 0% above the Healthcare Plans median of 25.66. The forward P/E on file is 11.36. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.23. The price-to-sales ratio is 0.3. On price-to-sales that is 31.77% below the Healthcare Plans median of 0.44. 11 Healthcare Plans companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +35.45%. Measured over 10 years, that is +3.45% a year compounded. The reported beta is 0.58. Daily returns over the trailing 10 years annualize to a volatility of 29.47%.

Growth & Income

Shareholders receive a dividend, yielding 2.74% on the latest price. That is 0.6 percentage points above the Healthcare Plans median yield of 2.18%. At the indicated rate that is $2.66 a share a year. The ex-dividend date on file is July 23, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $2.00 a share. The year before, 2025, totalled $2.66 a share.

The strongest complete calendar year on file is 2025 at +84.35%; the weakest is 2024 at −40.77%. Of the 9 complete calendar years on file, 3 finished higher. 2026 is still running; the price is +24.75% year to date.

Peer Comparison

CVS Health Corporation (CVS) operates in the Healthcare Plans industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
CVS Health Corporation CVS $123.73B 25.7
UnitedHealth Group Incorporated UNH $356.47B 25.5
Elevance Health, Inc. ELV $88.37B 18.4
The Cigna Group CI $74.65B 11.7

The Healthcare Plans industry average P/E ratio is 25.7x. CVS Health Corporation trades at a P/E of 25.7.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Healthcare Plans Stocks

UNH

UnitedHealth Group Incorporated

$356.47B

 ELV

Elevance Health, Inc.

$88.37B

 CI

The Cigna Group

$74.65B

 HUM

Humana Inc.

$48.22B

 CNC

Centene Corporation

$33.12B

 MOH

Molina Healthcare, Inc.

$10.48B
View all Healthcare Plans stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 NVS

Novartis AG

$304.10B
View all Healthcare stocks →

About CVS Health Corporation

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Visit website →